title: Defining Inflammatory Levels of Carotid Artery and Aortic18FDG Uptake: Implications for Clinical Trial Design and Individual Patient Management.
authors.affiliation: Department of Medicine (Cardiology Division), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: gewirtz.henry@mgh.harvard.edu.
authors.forename: Henry
authors.initials: H
authors.lastname: Gewirtz
authors.affiliation: Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
authors.forename: Vasken
authors.initials: V
authors.lastname: Dilsizian
mesh_terms: D001011:Aorta; D017536:Carotid Artery, Common; D002986:Clinical Trials as Topic; D019788:Fluorodeoxyglucose F18; D006801:Humans
chemical_list: D019788:Fluorodeoxyglucose F18
keywords: PET (18)FDG arterial uptake; carotid artery; clinical trials; target background ratio; vascular inflammation